Latest news
Take-Two’s (NASDAQ:TTWO) Q2 CY2026 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations Significantly - StockStoryStockStory · Fri, 07 Aug 2026 14:48:38 GMTArray (NASDAQ:ARRY) Posts Better-Than-Expected Sales In Q2 CY2026 But Quarterly Revenue Guidance Misses Expectations - StockStoryStockStory · Fri, 07 Aug 2026 14:48:38 GMTGlobus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations - StockStoryStockStory · Fri, 07 Aug 2026 09:19:06 GMTRE/MAX (NYSE:RMAX) Misses Q2 CY2026 Sales Expectations - StockStoryStockStory · Thu, 06 Aug 2026 23:08:54 GMTE.W. Scripps (NASDAQ:SSP) Misses Q2 CY2026 Sales Expectations - StockStoryStockStory · Thu, 06 Aug 2026 23:08:53 GMTAlta (NYSE:ALTG) Misses Q2 CY2026 Sales Expectations - StockStoryStockStory · Thu, 06 Aug 2026 22:16:40 GMT10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - StockStoryStockStory · Thu, 06 Aug 2026 22:16:40 GMTNature's Sunshine (NASDAQ:NATR) Misses Q2 CY2026 Sales Expectations, Stock Drops 14.3% - StockStoryStockStory · Thu, 06 Aug 2026 21:48:38 GMT